Search research articles
Contact Us
Filters
Showing results (31-40 of 133) with videos related to
Page
of 14
Sort By:
Clinical Parkinsonism & Related Disorders
|
July 28, 2021
Lidocaine injections and neck corset wearing improve dropped head syndrome in Parkinson's disease and related disorders
Yohei Mukai, Yoshihiko Furusawa, Yuko Morimoto, et al.
Biological & Pharmaceutical Bulletin
|
December 9, 2010
The utility of poly(γ-glutamic acid) nanoparticles as antigen delivery carriers in dendritic cell-based cancer immunotherapy
Keisuke Matsuo, Yumiko Ishii, Kazuhiko Matsuo, et al.
Parkinsonism & Related Disorders
|
May 16, 2015
Mechanism of camptocormia in Parkinson's disease analyzed by tilt table-EMG recording
Yoshihiko Furusawa, Takashi Hanakawa, Yohei Mukai, et al.
Biochemical and Biophysical Research Communications
|
September 8, 2007
Efficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides
Keisuke Matsuo, Tomoaki Yoshikawa, Atsushi Oda, et al.
Parkinsonism & Related Disorders
|
March 21, 2021
Prefrontal network dysfunctions in rapid eye movement sleep behavior disorder
Noritaka Wakasugi, Hiroki Togo, Yohei Mukai, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
June 24, 2008
[Small cerebellar vascular lesion can produce isolated conjugate deviation of the eyes]
Toshio Fukutake, Naoko Imoto, Yohei Mukai, et al.
Biochemical and Biophysical Research Communications
|
August 21, 2007
TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection
Xinglei Yao, Yasuo Yoshioka, Yusuke Eto, et al.
Biological & Pharmaceutical Bulletin
|
June 5, 2010
Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration
Xinglei Yao, Yasuo Yoshioka, Tomohiro Morishige, et al.
Plos One
|
December 19, 2015
A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
Shintaro Taki, Haruhiko Kamada, Masaki Inoue, et al.
Cytokine
|
December 19, 2012
Mutants of lymphotoxin-α with augmented cytotoxic activity via TNFR1 for use in cancer therapy
Tomohiro Morishige, Yasuo Yoshioka, Shogo Narimatsu, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 133) with videos related to
Sort By:
Page
of 14
Clinical Parkinsonism & Related Disorders
|
July 28, 2021
Lidocaine injections and neck corset wearing improve dropped head syndrome in Parkinson's disease and related disorders
Yohei Mukai, Yoshihiko Furusawa, Yuko Morimoto, et al.
Biological & Pharmaceutical Bulletin
|
December 9, 2010
The utility of poly(γ-glutamic acid) nanoparticles as antigen delivery carriers in dendritic cell-based cancer immunotherapy
Keisuke Matsuo, Yumiko Ishii, Kazuhiko Matsuo, et al.
Parkinsonism & Related Disorders
|
May 16, 2015
Mechanism of camptocormia in Parkinson's disease analyzed by tilt table-EMG recording
Yoshihiko Furusawa, Takashi Hanakawa, Yohei Mukai, et al.
Biochemical and Biophysical Research Communications
|
September 8, 2007
Efficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides
Keisuke Matsuo, Tomoaki Yoshikawa, Atsushi Oda, et al.
Parkinsonism & Related Disorders
|
March 21, 2021
Prefrontal network dysfunctions in rapid eye movement sleep behavior disorder
Noritaka Wakasugi, Hiroki Togo, Yohei Mukai, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
June 24, 2008
[Small cerebellar vascular lesion can produce isolated conjugate deviation of the eyes]
Toshio Fukutake, Naoko Imoto, Yohei Mukai, et al.
Biochemical and Biophysical Research Communications
|
August 21, 2007
TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection
Xinglei Yao, Yasuo Yoshioka, Yusuke Eto, et al.
Biological & Pharmaceutical Bulletin
|
June 5, 2010
Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration
Xinglei Yao, Yasuo Yoshioka, Tomohiro Morishige, et al.
Plos One
|
December 19, 2015
A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
Shintaro Taki, Haruhiko Kamada, Masaki Inoue, et al.
Cytokine
|
December 19, 2012
Mutants of lymphotoxin-α with augmented cytotoxic activity via TNFR1 for use in cancer therapy
Tomohiro Morishige, Yasuo Yoshioka, Shogo Narimatsu, et al.
Page
of 14